Liv Pure Peptide Product: IGF-1 DES

Liv Pure Peptides IGF-1 DES (INSULIN-LIKE GROWTH FACTOR 1 DES) Categories: Hormone Optimization, Fitness & Performance $125.00 CAS# 57773-65-6 Formula: C319H501N91O96S7 Molecular Weight: 7370.870 g/mol

IGF-1 DES, a synthetic peptide fragment consisting of 67 amino acids, is related to the naturally occurring insulin-like growth factor 1. Widely studied in laboratories, IGF-1 DES is utilized in research exploring cellular growth, differentiation, and tissue metabolism. The compound is supplied as a stable lyophilized powder, designed to facilitate controlled experimental studies across biomedical and cellular research fields.

For Research Use Only – Not for Human Consumption.

Out of Stock

Sizes

Liv Pure Peptides Products: IGF-1 DES 2mg

At Liv Pure Peptides, innovation meets purity. Our advanced research and rigorous quality standards deliver breakthrough peptide solutions for better health and science.

Shop Products

Products

Pages

Legal

Newsletter Signup

YOU MUST BE OVER 21 YEARS OLD TO USE THIS WEBSITE.

All products provided by Liv Pure are intended solely for in‑vitro laboratory research purposes. These materials are expressly forbidden for any form of human or animal use, ingestion, or administration, and all products are sold strictly for research, laboratory, or analytical purposes – not for human consumption.

The products offered on this platform are not formulated, designed, or intended to diagnose, cure, mitigate, treat, or prevent any diseases or medical conditions. Additionally, these statements have not been evaluated by the Food and Drug Administration, and our products are not intended to diagnose, treat, cure, or prevent any disease.

All products are for Research and Development use only and are not for human consumption.

Liv Pure is a chemical supplier; LIV Pure Peptides is not a compounding pharmacy or chemical compounding facility as defined under Section 503A of the Federal Food, Drug, and Cosmetic Act, nor is it an outsourcing facility as defined under Section 503B of the Act.